HIV/AIDS-Associated Infection
TSP/HAM should be considered in HIV patients with myelopathy and normal CD4 counts
Published in AIDS Weekly, October 31st, 2005
"Tropical spastic paraparesis/human T leukemia virus type 1 (HTLV-1)-associated myelopathy (TSP/HAM) is rarely reported in the United States. The causative agents of TSP/HAM are HTLV-1 and, possibly, its cosmopolitan variant, human T leukemia virus type 2 (HTLV-2)," scientists writing in the journal Clinical Infectious Diseases report.
"Among HTLV-1-or HTLV-2-monoinfected individuals, the estimated lifetime risk for development of TSP/HAM is <2%. However, it has been suggested that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-10-31)
More Articles from AIDS Weekly
- HIV/AIDS Coinfection
GBV-C inhibition of HIV mediated by CD4 and CD8 T-cell-derived soluble factors - HIV/AIDS HAART
Cotrimoxazole prophylaxis prevents complications prior to HAART initiation - HIV/AIDS HAART
De novo drug-resistance mutations selected during first HAART interruption cycle - HIV/AIDS Prophylaxis
Single-dose nevirapine within 24 hours of birth protects against HIV-1 infection - HIV/AIDS-Related Lipodystrophy
Growth hormone releasing factor improves lipid levels in HIV/AIDS - Antimicrobials
Plant extracts have antimicrobial activity against HIV-related fungal pathogens - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
